Manmeet S. Ahluwalia, MD, MBA, FASCO - Capitalizing on Personalized Care in IDH-Mutant Gliomas: Expert Guidance on the Use of Biomarker Testing and Targeted Therapies in Real-World Settings

PeerView Internal Medicine CME/CNE/CPE Video Podcast

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/HZS865. CME/MOC/AAPA credit will be available until December 21, 2025.

Capitalizing on Personalized Care in IDH-Mutant Gliomas: Expert Guidance on the Use of Biomarker Testing and Targeted Therapies in Real-World Settings

In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and American Brain Tumor Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported by an educational grant from Servier Pharmaceuticals.

Disclosure information is available at the beginning of the video presentation.